Trial
NCT00356928
Cyclophosphamide Plus T-Cell Transplantation for Patients With Hematologic Malignancies
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
National Cancer Institute (NCI)
Condition
Leukemia
Intervention
Cyclophosphamide
Why stopped
Poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-08-20